Status:
COMPLETED
A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)
Lead Sponsor:
ThromboGenics
Conditions:
Vitreomacular Traction
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
A multicenter study to compare multiple doses of intravitreal microplasmin for non-surgical PVD induction for treatment of patients with vitreomacular traction.
Eligibility Criteria
Inclusion
- Patients \>\_ 18 years of age with vitreomacular traction
Exclusion
- PVD present at baseline
- Certain vitreoretinal conditions including proliferative disease, rhegmatogenous retinal detachment, and proliferative vitreoretinopathy (PVR)
- Vitreous hemorrhage
- Patients who have had a vitrectomy in the study eye at any time
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00435539
Start Date
February 1 2007
End Date
February 1 2009
Last Update
December 17 2014
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
ZNA OCMW Antwerpen
Antwerp, Belgium, 2020
2
University Hospital of Ghent
Ghent, Belgium, B-9000
3
Universitaire Ziekenhuizen K.U.Leuven
Leuven, Belgium
4
Augenklinik der Universitat Munchen
München, Germany, 80336